B
MRNA icon

Bellecapital’s Moderna MRNA Stock Holding History

Bellecapital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,540
Closed -$237K – 180
2023
Q1 		$237K Hold
1,540
– – 0.06% 175
2022
Q4 		$277K Buy
+1,540
New +$252K 0.08% 160
2022
Q3 		– Sell
-7,716
Closed -$1.1M – 199
2022
Q2 		$1.1M Hold
7,716
– – 0.31% 66
2022
Q1 		$1.33M Buy
7,716
+385
+5% +$64.8K 0.42% 52
2021
Q4 		$1.86M Sell
7,331
-1,558
-18% -$456K 0.53% 43
2021
Q3 		$3.42M Buy
8,889
+150
+2% +$55.3K 1.04% 28
2021
Q2 		$2.05M Buy
8,739
+1,629
+23% +$291K 0.62% 39
2021
Q1 		$931K Buy
+7,110
New +$1.03M 0.29% 64

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellecapital's MRNA Position: Q2 2023 in Review

Bellecapital sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,540 shares — an estimated $237K sold.

Bellecapital first reported a position in MRNA in Q1 2021 and held it in 8 quarters. The position peaked at $3.42M in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Bellecapital reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Bellecapital sold 1,540 Moderna shares in Q2 2023, an estimated $237K.
  • Bellecapital first reported a position in Moderna in Q1 2021 and held it in 8 quarters.
  • Bellecapital's Moderna position peaked at $3.42M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Bellecapital's 13F filing for Q2 2023, filed 7 Jul 2023.